Primary Site >> Colorectal Cancer

Gene >> LRBA

  • 2010
  • 2015
  • 2017
  • 2018
Ref: Blood glucose level normalization and accurate timing improves the accuracy of PET-based treatment response predictions in rectal cancer.
PMID: 20176406
Ref: Diagnostic accuracy and impact on management of (18)F-FDG PET and PET/CT in colorectal liver metastasis: a meta-analysis and systematic review.
PMID: 25319712
Ref: LBA-007FOLFOX/Bevacizumab +/- Irinotecan in advanced colorectal cancer (AIO) "CHARTA": Final results and multivariate prognostic factor analysis.
PMID: 30052789
Ref: LBA-010Prognostic utility of immune markers and validation of Immunoscore in stage III colon carcinoma patients treated with adjuvant FOLFOX in a phase III trial (NCCTG N0147; Alliance).
PMID: 30052792
Ref: Screening for susceptibility genes in hereditary non-polyposis colorectal cancer.
PMID: 29844832